{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

Reminder to fill-in Arab-speaking seminar survey

The survey for MSIF’s planned Arab-speaking seminar closes this week - Friday 16 May.

In 2007, MSIF made it a key priority to provide support for the development of new and existing national MS societies and has identified Arab-speaking countries for its second Development Seminar. The aims of the seminar are to encourage and facilitate the sharing of information, skills and experience and determine development projects and programmes to be established.

read more

Living with MS: Montréal08 website live now

On 16 September 2008, MSIF and the MS Society of Canada will be holding Montréal08 - Living with MS: Global Perspectives on Current Issues in Montréal, Quebec, Canada.

read more

back to top

Profile of the Month : June 2008

Country: Indonesia
Age: 36
Occupation: Writer, Tenant Relations Officer
Type of MS: Relapsing–remitting MS
Year of Diagnosis: 2001

"Help me with empathy, not sympathy"1

English Italiano Deutsche Espanol Francais Русско

back to top

Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients : Saccade test analysis.

Eye movement disorders, particularly internuclear ophthalmoplegia (INO), are common in people with MS. The authors found that the saccade test analysis which is part of the electrooculographic evaluation, is useful for identifying subclinical INO signs in people with MS.

authors: Jozefowicz-Korczynska M, Lukomski M, Pajor A.

source: J Neurol. 2008 May 2 [Epub ahead of print]

read more

Does high field MRI allow an earlier diagnosis of multiple sclerosis?

The authors investigated whether high field MRI (i.e. 3 Tesla scanner) can provide an earlier diagnosis of definite MS compared with 1.5 Tesla. They concluded that, although it showed a higher detection rate of inflammatory brain lesions, high field MRI cannot lead to a earlier diagnosis of lesion dissemination in time and therefore definite MS.

authors: Wattjes MP, Harzheim M, Lutterbey GG, Hojati F, Simon B, Schmidt S, Schild HH, Barkhof F.

source: J Neurol. 2008 May 2 [Epub ahead of print]

read more

Multiple sclerosis: new treatment trials and emerging therapeutic targets.

This review gives an overview of the up-to-date therapeutic strategies and the new drugs which are currently studied in clinical trials.

authors: Deangelis T, Lublin F.

source: Curr Opin Neurol. 2008 Jun;21(3):261-71.

read more

Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes.

The authors investigated the immunomodulatory role of simvastatin, a medication which is used as cholesterol-lowering agent, in people with MS. They found that this drug can interfere in the autoimmune response, but further studies are needed to assess its clinical benefit.

authors: Zhang X, Jin J, Peng X, Ramgolam VS, Markovic-Plese S.

source: J Immunol. 2008 May 15;180(10):6988-96.

read more

back to top

Ireland: new, nationwide programme for people with MS

"Getting The Balance Right" is MS Ireland’s first-ever nationwide exercise, health promotion and research programme for people with MS, and will be delivered across the country in a variety of venues and settings.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.